Catalyst Pharmaceuticals, Inc.
2019 Q4 - 2025 Q4 (25 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).
| All 13F Holders | Filing date | Value ($000s) | % of Holdings | Shares | Reporting period |
|---|---|---|---|---|---|
| 2025 Q4 | 1/27/2026 | 1,135 | 0.0% | 48,643 | 12/31/2025 |
| 2025 Q3 | 11/14/2025 | 747 | 0.0% | 37,894 | 9/30/2025 |
| 2025 Q2 | 8/7/2025 | 692 | 0.0% | 31,890 | 6/30/2025 |
| 2025 Q1 | 5/7/2025 | 774 | 0.0% | 31,897 | 3/31/2025 |
| 2024 Q4 | 2/7/2025 | 598 | 0.0% | 28,653 | 12/31/2024 |
| 2024 Q3 | 11/14/2024 | 499 | 0.0% | 25,080 | 9/30/2024 |
| 2024 Q2 | 7/29/2024 | 382 | 0.0% | 24,692 | 6/30/2024 |
| 2024 Q1 | 4/25/2024 | 394 | 0.0% | 24,692 | 3/31/2024 |
| 2023 Q4 | 1/30/2024 | 415 | 0.0% | 24,692 | 12/31/2023 |
| 2023 Q3 | 10/25/2023 | 289 | 0.0% | 24,692 | 9/30/2023 |
| 2023 Q2 | 8/7/2023 | 264 | 0.0% | 19,648 | 6/30/2023 |
| 2023 Q1 | 5/8/2023 | 326 | 0.0% | 19,648 | 3/31/2023 |
| 2022 Q4 | 2/1/2023 | 283 | 0.0% | 15,223 | 12/31/2022 |
| 2022 Q3 | 11/9/2022 | 119 | 0.0% | 9,240 | 9/30/2022 |
| 2022 Q2 | 8/9/2022 | 65 | 0.0% | 9,240 | 6/30/2022 |
| 2022 Q1 | 4/21/2022 | 137 | 0.0% | 16,535 | 3/31/2022 |
| 2021 Q4 | 2/1/2022 | 56 | 0.0% | 8,277 | 12/31/2021 |
| 2021 Q3 | 11/15/2021 | 37 | 0.0% | 6,904 | 9/30/2021 |
| 2021 Q2 | 7/30/2021 | 40 | 0.0% | 6,904 | 6/30/2021 |
| 2021 Q1 | 5/3/2021 | 32 | 0.0% | 6,904 | 3/31/2021 |
| 2020 Q4 | 1/28/2021 | 23 | 0.0% | 6,904 | 12/31/2020 |
| 2020 Q3 | 11/6/2020 | 21 | 0.0% | 6,904 | 9/30/2020 |
| 2020 Q2 | 7/28/2020 | 32 | 0.0% | 6,904 | 6/30/2020 |
| 2020 Q1 | 5/6/2020 | 27 | 0.0% | 6,904 | 3/31/2020 |
| 2019 Q4 | 1/21/2020 | 26 | 0.0% | 6,904 | 12/31/2019 |